81 related articles for article (PubMed ID: 1914016)
1. [Pathologic study on megakaryocytes in chronic myeloproliferative disorders].
Lin N; Liang P
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):113-5. PubMed ID: 1914016
[TBL] [Abstract][Full Text] [Related]
2. Human megakaryocytes. III. Characterization in myeloproliferative disorders.
Rabellino EM; Levene RB; Nachman RL; Leung LL
Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121
[TBL] [Abstract][Full Text] [Related]
3. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
4. Megakaryocyte markers in myeloproliferative disorders.
Iványi JL; Kiss A; Telek B; Tornai I
Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475
[TBL] [Abstract][Full Text] [Related]
5. Analysis of megakaryocyte ploidy in patients with thrombocytosis.
Kanz L; Hollen C; Friese P; Burstein SA
Int J Cell Cloning; 1990 Jul; 8(4):299-306. PubMed ID: 2401806
[TBL] [Abstract][Full Text] [Related]
6. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
Ohshima K; Kikuchi M; Takeshita M
J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-platelet glycoprotein Ib and/or IIb/IIIa autoantibodies on the size of megakaryocytes in patients with immune thrombocytopenia.
Hasegawa Y; Nagasawa T; Kamoshita M; Komeno T; Itoh T; Ninomiya H; Abe T
Eur J Haematol; 1995 Sep; 55(3):152-7. PubMed ID: 7672087
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
Thiele J; Holgado S; Choritz H; Georgii A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(1-2):67-81. PubMed ID: 6134385
[TBL] [Abstract][Full Text] [Related]
9. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders--analysis of planimetric and numeric characteristics by means of a knowledge based system.
Nafe R; Kaloutsi V; Fritsch RS; Georgii A
Exp Pathol; 1990; 40(4):213-9. PubMed ID: 2098268
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities.
Kaloutsi V; Fritsch RS; Buhr T; Restrepo-Specht I; Widjaja W; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):493-7. PubMed ID: 2058083
[TBL] [Abstract][Full Text] [Related]
11. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
Thiele J; Titius BR; Kopsidis C; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
[TBL] [Abstract][Full Text] [Related]
12. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
[TBL] [Abstract][Full Text] [Related]
13. Human megakaryocyte polyploidization is associated with a decrease in GPIIIA expression.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(6B):5187-9. PubMed ID: 10697532
[TBL] [Abstract][Full Text] [Related]
14. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
Chuang SS; Jung YC; Li CY
Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
[TBL] [Abstract][Full Text] [Related]
16. Low megakaryocyte ploidy in Ph-positive chronic myelogenous leukemia measured by flow cytometry.
Jacobsson S; Wadenvik H; Kutti J; Swolin B
Am J Clin Pathol; 1999 Feb; 111(2):185-90. PubMed ID: 9930139
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of megakaryocytes by endothelial markers: a comparative study.
Calapso P; Vitarelli E; Crisafulli C; Tuccari G
Pathologica; 1992; 84(1090):215-23. PubMed ID: 1437309
[TBL] [Abstract][Full Text] [Related]
19. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
20. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
